These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1029 related articles for article (PubMed ID: 20203102)
1. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Veilleux A; Houde VP; Bellmann K; Marette A Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102 [TBL] [Abstract][Full Text] [Related]
2. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes. Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463 [TBL] [Abstract][Full Text] [Related]
3. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase. Adochio R; Leitner JW; Hedlund R; Draznin B Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408 [TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling. Gao S; Duan C; Gao G; Wang X; Yang H Int J Biochem Cell Biol; 2015 Jul; 64():25-33. PubMed ID: 25813876 [TBL] [Abstract][Full Text] [Related]
6. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661 [TBL] [Abstract][Full Text] [Related]
7. Fisetin regulates obesity by targeting mTORC1 signaling. Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912 [TBL] [Abstract][Full Text] [Related]
8. Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition. Han EK; Leverson JD; McGonigal T; Shah OJ; Woods KW; Hunter T; Giranda VL; Luo Y Oncogene; 2007 Aug; 26(38):5655-61. PubMed ID: 17334390 [TBL] [Abstract][Full Text] [Related]
9. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Khamzina L; Veilleux A; Bergeron S; Marette A Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1. El-Chaâr D; Gagnon A; Sorisky A Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836 [TBL] [Abstract][Full Text] [Related]
17. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909 [TBL] [Abstract][Full Text] [Related]
18. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583 [TBL] [Abstract][Full Text] [Related]